Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1129
Selected: 0
NCT IDTitle
NCT02960880Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists
NCT03523442A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
NCT05014360A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
NCT03965741Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners
NCT01021670An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride
NCT04033445A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04655807A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease
NCT05379634A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
NCT04883619A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
NCT05112666A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)
NCT04951622A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
NCT07822529A Study of Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel Disease
NCT04988295A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
NCT06618001A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
NCT01685983A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer
NCT04609826A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT04657224A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
NCT04397276A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors
NCT04282746A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants
NCT05050097A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
NCT04960124A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants
NCT04223349A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants
NCT02345148Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult Participants
NCT02336685Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001
NCT01998958A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression
NCT00747526A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive
NCT03242278Real-world Dosing Patterns of Rivaroxaban in the United States
NCT01776840A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT05236868A Study of JNJ-42847922 (Seltorexant) in Healthy Participants
NCT02690155Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
NCT02841150Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules
NCT02293681An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
NCT05521087A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias
NCT04087681Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)
NCT01134536Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents
NCT01427699A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
NCT06193863An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
NCT02659735A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation
NCT01900574A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
NCT01779791A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma
NCT03333317A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus
NCT04816513A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants
NCT06095115A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
NCT02765490Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection
NCT00606476AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease
NCT07223125A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
NCT02413489An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
NCT03249506Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)
NCT03080987A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants
NCT04102111A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease